Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | GlaxoSmithKline Biologicals SA | 55 |
| 2 | Eisai Co Ltd | 20 |
| 3 | Cornell University | 14 |
| 4 | Nisshin Seifun Group Inc | 13 |
| 5 | Janssen Pharmaceuticals Inc | 12 |
| 6 | Purdue Research Foundation | 12 |
| 7 | North Carolina State University | 11 |
| 8 | Toyota Motor Corp | 11 |
| 9 | University of Iowa Research Foundation | 11 |
| 10 | AstraZeneca AB | 10 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 230 |
| 2 | C07K | Peptides | 177 |
| 3 | A61P | Therapeutic activity (drug indications) | 175 |
| 4 | C12N | Microorganisms, enzymes | 165 |
| 5 | Y02A | Climate change adaptation | 91 |
| 6 | C12P | Fermentation, enzyme processes | 87 |
| 7 | C12Y | Enzyme nomenclature (EC numbers) | 60 |
| 8 | C12Q | Measuring/testing involving enzymes | 55 |
| 9 | C12R | 34 | |
| 10 | G01N | Investigating / analysing materials | 32 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Use of undecaprenol kinase inhibitors to inhibit cell wall biosynthesis | 2001 | ユニバーシティー オブ フロリダ | 0 |
| USE OF INHIBITORS OF UNDECAPRENOL KINASE TO INHIBIT CELL WALL BIOSYNTHESIS | 2000 | University of Florida | 0 |
| USE OF INHIBITORS OF UNDECAPRENOL KINASE TO INHIBIT CELL WALL BIOSYNTHESIS | 1998 | University of Florida | 0 |
| Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis | 1998 | University of Florida | 0 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Dominique Mengin‐Lecreulx | Institut de Biochimie et Biophysique Moléculaire et Cellulaire | 2 |
| 2 | Frederic A. Troy | University of California, Davis | 2 |
| 3 | Mary Osborn | UConn Health | 2 |
| 4 | Tadeusz Chojnacki | Polish Academy of Sciences | 2 |
| 5 | Adrien Ducret | Lyon 1 Université | 1 |
| 6 | Ahmed Bouhss | Institut de Biochimie et Biophysique Moléculaire et Cellulaire | 1 |
| 7 | Amy E. Trunkfield | University of Warwick | 1 |
| 8 | Anna Müller | University of Bonn | 1 |
| 9 | Barbara C. McGrath | UConn Health | 1 |
| 10 | Bruce E. Holbein | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Close Is Not Enough | 2000 | 302 | Lipid Membrane Structure and Behavior |
| An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimurium. | 1983 | 102 | Lipid Membrane Structure and Behavior |
| Quantitative high-performance liquid chromatography analysis of the pool levels of undecaprenyl phosphate and its derivatives in bacterial membranes | 2008 | 93 | Bacterial Genetics and Biotechnology |
| 2H NMR investigation of the organization and dynamics of polyisoprenols in membranes. | 1985 | 65 | Lipid Membrane Structure and Behavior |
| The Stress-Responsive <i>dgk</i> Gene from <i>Streptococcus mutans</i> Encodes a Putative Undecaprenol Kinase Activity | 2003 | 50 | Genomics and Phylogenetic Studies |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of undecaprenol?
Which organizations hold the most patents related to undecaprenol?
What is the primary research focus of published papers on undecaprenol?
What patent classifications are most common for undecaprenol-related inventions?
How has patent activity for undecaprenol evolved in recent years?